<DOC>
	<DOCNO>NCT02797405</DOCNO>
	<brief_summary>THEODORA prospective pilot clinical trial aim first evaluate validate predictive value A &amp; MS bioassay tumor control radiotherapy .</brief_summary>
	<brief_title>Tumour HEalthy Tissues DOse-response Radiosensitivity Assay</brief_title>
	<detailed_description>For purpose , project compose 3 stage : - A Calibration stage allow evaluate correlation clinical tumor response parameter ( i.e . TV/AP feature ) radiobiological parameter issue A/MS bioassay order develop mathematic model define UTCR parameter - A Validation stage order assess validity A/MS bioassay towards clinical tumour response parameter ( i.e . TV/AP feature UTCR ) . - A Precision stage perform either improve precision predictive performance A MS bioassay establish new mathematical model describe correlation clinical radiobiological parameter . The objective precision stage depend result calibration stage ( see ) . This prospective clinical study conduct population patient different tumor type order explore large range tumor radiosensitivity include sarcoma , rectal carcinoma esophagus tumor .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>I1 . Patients ( male female ) â‰¥ 18 year age . I2 . Adult patient suspect , nontreated , nonmetastatic retroperitoneal limb soft tissue sarcoma , esophagus cancer rectum cancer treat preoperative radiotherapy radiochemotherapy I3 . At least one measurable lesion per RECIST 1.1 I4 . Documented negative serology test ( HVB , HIV , HVC ) I5 . PS ECOG 0 1 I6 . Patient able willing provide inform consent . I7 . Ability understand willingness followup visit . I8 . Covered medical insurance . E1 . Contraindication radiotherapy E2 . Contraindication skin biopsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>radiation therapy</keyword>
	<keyword>radiosensitivity</keyword>
	<keyword>vitro diagnostic medical device</keyword>
	<keyword>Adverse Event post radiotherapy</keyword>
</DOC>